You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Venclyxto

Showing 101 - 115 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Nov 30, 2021

Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia Trial in United States (Ibrutinib, Rituximab, Venetoclax)

Suspended
  • Lymphoplasmacytic Lymphoma
  • Waldenstrom Macroglobulinemia
  • Centralia, Illinois
  • +73 more
Jul 27, 2022

High Grade B-Cell Lymphoma, Not Otherwise Specified, Recurrent Burkitt Lymphoma, Recurrent DLBCL Trial in New Brunswick

Withdrawn
  • High Grade B-Cell Lymphoma, Not Otherwise Specified
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jun 12, 2020

Disease State in Adult Acute Myeloid Leukemia Receiving Oral

Not yet recruiting
  • Acute Myeloid Leukemia
    • Medellin, Antioquia, Colombia
    • +6 more
    Oct 18, 2022

    Disease State in Adult Acute Myeloid Leukemia Ineligible for

    Recruiting
    • Acute Myeloid Leukemia
      • Athens, Attiki, Greece
      • +11 more
      Jan 26, 2023

      Disease State in Adult Acute Myeloid Leukemia Ineligible for

      Not yet recruiting
      • Acute Myeloid Leukemia
        • Calgary, Alberta, Canada
        • +9 more
        Jun 15, 2022

        Disease State in Adult Acute Myeloid Leukemia Ineligible for

        Recruiting
        • Acute Myeloid Leukemia
          • Luzern 16, Luzern, Switzerland
          • +9 more
          May 2, 2022

          Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

          Not yet recruiting
          • Acute Myeloid Leukemia (AML)
          • Leipzig, Germany
            Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
          Apr 25, 2023

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)

          Recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • Phoenix, Arizona
          • +116 more
          Jun 27, 2022

          Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)

          Recruiting
          • Chronic Lymphocytic Leukemia
          • Fountain Valley, California
          • +201 more
          Jan 16, 2023

          Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)

          Recruiting
          • Chronic Lymphocytic Leukemia (CLL)
          • Small Lymphocytic Lymphoma (SLL)
          • Nagoya-shi, Aichi, Japan
          • +19 more
          Jan 25, 2023

          Chronic Lymphoid Leukemia Trial in Worldwide (Ibrutinib, Venetoclax, Obinutuzumab)

          Recruiting
          • Chronic Lymphoid Leukemia
          • Ibrutinib
          • +2 more
          • Graz, Austria
          • +180 more
          Jan 21, 2022

          Chronic Lymphocytic Leukemia Trial in Worldwide (Fludarabine, Cyclophosphamide, Rituximab)

          Active, not recruiting
          • Chronic Lymphocytic Leukemia
          • Wien, Austria
          • +160 more
          Sep 29, 2021

          Adverse Events and Change in Disease Activity in Participants of

          Recruiting
          • Acute Myeloid Leukemia (AML)
            • Anjo-shi, Aichi, Japan
            • +233 more
            Jan 12, 2023

            Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)

            Recruiting
            • Chronic Lymphocytic Leukemia
            • Small Lymphocytic Lymphoma
            • Obinutuzumab
            • +3 more
            • Birmingham, Alabama
            • +484 more
            Aug 24, 2022